WRN promoter CpG island hypermethylation does not predict...

  • Main
  • 2016 / 04
  • WRN promoter CpG island hypermethylation does not predict...
Clinical Cancer Research 2016 / 04

WRN promoter CpG island hypermethylation does not predict more favorable outcomes for metastatic colorectal cancer patients treated with irinotecan-based therapy

Bosch, L. J. W., Luo, Y., Valinluck Lao, V., Snaebjornsson, P., Trooskens, G., Vlassenbroeck, I., Mongera, S., Tang, W., Welcsh, P., Herman, J. G., Koopman, M., Nagtegaal, I., Punt, C. J. A., Van Crie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-15-2703
Date:
April, 2016
File:
PDF, 1.29 MB
english, 2016
Conversion to is in progress
Conversion to is failed